Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001127602-18-036571
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-12-18 16:22:10
Reporting Period:
2018-12-14
Accepted Time:
2018-12-18 16:22:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
885590 Bausch Health Companies Inc. BHC Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1683323 Thomas Appio 400 Somerset Corporate Boulevard
Bridgewater NJ 08807
Pres&co-Head Bausch&lomb/int'l No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, No Par Value Acquisiton 2018-12-14 25,440 $22.96 128,922 No 4 P Direct
Common Stock, No Par Value Acquisiton 2018-12-14 25,440 $0.00 154,362 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 A Direct
Footnotes
  1. The price in Column 4 is a weighted average price. The prices actually paid in this transaction are within the range of $22.94 to $22.96 per share. Upon request by the Commission staff, the Issuer or the reporting person will provide full information regarding the number of Common Shares purchased by the reporting person at each separate price within the range set forth in this footnote.
  2. Represents matching Restricted Share Units ("MRSUs") granted to the Reporting Person in connection with the open market purchase of Common Shares of the Issuer reported above (the "Purchased Shares"), pursuant to the Issuer's Matching Share Program. One-third of the MRSUs will vest on each of the first, second, and third anniversaries following the date of grant ("MRSU Grant Date"), subject to the Reporting Person's continued service (except in limited circumstances).